Shadi Esfahani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with.

United statesShadi esfahaniSherly mosessianFrank vallaClinical developmentHeidelberg universityFibroblast activation protein inhibitorNon randomized studyPrincipal investigatorScientific officerColorectal cancerPancreatic ductal adenocarcinomaActivation proteinSofie biosciences